Previous studies also showed that Sema4d loss could facilitate oligodendrocyte recovery, reduce blood–brain barrier permeability, inhibit the proinflammatory response, curb ischemia-induced cortex cell death, and ameliorate postischemic behavioral abnormalities in the MCAO/R-induced cerebral stroke model (72–74). Here, SEMA4D is linked to ischemia.